Author: Laura Kaiser

Immuto Scientific, Inc., a biotechnology company spun out of the University of Wisconsin-Madison, announced today that it has successfully closed on a $2.3 million seed-funding round. The funding will enable the Madison-based company to scale-up equipment and staffing to provide commercial analytical research services to already-identified...

Abstract: 19.4 patients per million experience myocarditis after COVID-19 vaccination, which is not much higher than baseline rates. 8 Oct 2021 Dual Team Study Team A: Howard Bregman, MD | Eric Barkley Team B: Christopher Alban, MD, MBA | Xander Posner, MPH | Joe Deckert, PhD Recent studies1,2 have suggested a possible association between...

Machine learning systems are helping researchers in Wisconsin discover promising drug candidates through more efficient data analysis.  Tony Gitter is an associate professor in the Department of Biostatistics and Medical Informatics at UW-Madison, and an investigator at the Morgridge Institute for Research. Speaking today at the...

Grants totaling more than $550,000 to increase access and enhance quality care in rural Wisconsin were announced today by the Wisconsin Department of Health Services (DHS). The grants support education and training to assist rural hospitals and clinics in filling “high need, high demand” positions. “Ensuring...

The latest seven-day average of new COVID-19 cases in the state was 2,532 cases per day, the Department of Health Services site shows.  Although the average has dropped slightly over the past week or so from the recent peak of 2,932 cases per day, it remains...

By Megan Provost ’20 An electron microscope image of the scaffold used for growing retinal cells. An interdisciplinary effort among UW–Madison researchers is the next step toward curing once-irreversible vision loss. David Gamm, professor of ophthalmology and visual sciences at the UW School of Medicine and Public Health and director of...